Title: Relapse rate and predictors of relapse after cessation of glucocorticoid maintenance
therapy in type 1 autoimmune pancreatitis: a multicenter retrospective study
Version: 2 Date: 25 Jul 2023
Reviewer:  María Sánchez-Castañón
Reviewer's report:
Dear authors:
It would be appropiate to include in the clinical characteristics of the  patients, the serum
IgG levels and the presence/ausence of hypergammaglonulinemia and the  histopathological
Features. Do you have studied the presence of autoantibodies associated with AIP, such as
anti-carbonic anhydrase II, anti-pancreas secretory trypsin inhibitor (anti-PSTI) or anti-amylase
alpha antibodies ?  to include  these data in the paper.
In the results, It would be appropiate to   include in the multivariate analysis ,     elevated serum
IgG levels,  presence of hypergammaglobulinemia, presence of autoantibodies an number of
extrapancreatic lessions.
Regarding the treatment,  patients  have received any other  therapy?
Regarding the relapse,  has any patient developed cancer?
Title: Relapse rate and predictors of relapse after cessation of glucocorticoid maintenance
therapy in type 1 autoimmune pancreatitis: a multicenter retrospective study
Version: 2 Date: 25 Jul 2023
Reviewer:  María Sánchez-Castañón
Reviewer's report:
Dear authors:
It would be appropiate to include in the clinical characteristics of the  patients, the serum
IgG levels and the presence/ausence of hypergammaglonulinemia and the  histopathological
Features. Do you have studied the presence of autoantibodies associated with AIP, such as
anti-carbonic anhydrase II, anti-pancreas secretory trypsin inhibitor (anti-PSTI) or anti-amylase
alpha antibodies ?  to include  these data in the paper.
In the results, It would be appropiate to   include in the multivariate analysis ,     elevated serum
IgG levels,  presence of hypergammaglobulinemia, presence of autoantibodies an number of
extrapancreatic lessions.
Regarding the treatment,  patients  have received any other  therapy?
Regarding the relapse,  has any patient developed cancer?
Please review this paper.
user
Title: Relapse rate and predictors of relapse after cessation of glucocorticoid maintenance
therapy in type 1 autoimmune pancreatitis: a multicenter retrospective study
Version: 2 Date: 25 Jul 2023
Reviewer:  María Sánchez-Castañón
Reviewer's report:
Dear authors:
It would be appropiate to include in the clinical characteristics of the  patients, the serum
IgG levels and the presence/ausence of hypergammaglonulinemia and the  histopathological
Features. Do you have studied the presence of autoantibodies associated with AIP, such as
anti-carbonic anhydrase II, anti-pancreas secretory trypsin inhibitor (anti-PSTI) or anti-amylase
alpha antibodies ?  to include  these data in the paper.
In the results, It would be appropiate to   include in the multivariate analysis ,     elevated serum
IgG levels,  presence of hypergammaglobulinemia, presence of autoantibodies an number of
extrapancreatic lessions.
Regarding the treatment,  patients  have received any other  therapy?
Regarding the relapse,  has any patient developed cancer?
assistant